Genelabs Technologies
Genelabs Technologies's phone number is 650-369-9500
.
As of January 6, 2009, Genelabs Technologies Inc. was acquired by SmithKline Beecham Corporation. Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of infectious disease therapies to improve human health. The company's product pipeline consists of infectious disease projects focusing on Hepatitis C virus infection; and late-stage clinical assets, including an investigational vaccine for hepatitis E virus that is being developed by GlaxoSmithKline; and Prestara, an investigational drug for systemic lupus erythematosus. It h...
read more
As of January 6, 2009, Genelabs Technologies Inc. was acquired by SmithKline Beecham Corporation. Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of infectious disease therapies to improve human health. The company's product pipeline consists of infectious disease projects focusing on Hepatitis C virus infection; and late-stage clinical assets, including an investigational vaccine for hepatitis E virus that is being developed by GlaxoSmithKline; and Prestara, an investigational drug for systemic lupus erythematosus. It has license and collaboration agreement with the Novartis Institutes for BioMedical Research for HCV polymerase non-nucleoside discovery research. Genelabs Technologies also has a collaborative research agreement with the National Health Research Institutes and Genovate Biotechnology Co., Ltd. to discover and develop compounds that target the hepatitis C virus. The company was founded in 1983 and is headquartered in Redwood City, California.
show less
Website | genelabs.com | |
Industry | Biotechnology | |
Location | United States | |
Employees | 22 | |
Founded | 1983 |
HQ | 505 Penobscot Drive | |
Phone | 650-369-9500 | |
Funding | 17,300,000 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | genelabs.com | |
Industry | Biotechnology | |
Location | United States | |
Employees | 22 | |
Founded | 1983 | |
linkedin.com/company/genelabs-technologies | ||
HQ | 505 Penobscot Drive | |
Phone | 650-369-9500 | |
Funding | 17,300,000 USD |
Email Patterns for Genelabs Technologies
Top Competitors for Genelabs Technologies
Genelabs Technologies Questions
Where are Genelabs Technologies's headquarters?
Genelabs Technologies's headquarters are in 505 Penobscot Drive
What is Genelabs Technologies's phone number?
Genelabs Technologies's phone number is 650-369-9500
What is Genelabs Technologies's official website?
Genelabs Technologies's website is genelabs.com
How many employees are working in Genelabs Technologies right now?
Genelabs Technologies has
22 employees.
View the Email and Phone Numbers for all 22 working at Genelabs Technologies.
What is Genelabs Technologies's industry?
Genelabs Technologies's industry is
Biotechnology
Who are Genelabs Technologies's top competitors?
Genelabs Technologies's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What are Genelabs Technologies's categories?
Genelabs Technologies's categories are Biopharma, Biotechnology, Health Care, Therapeutics
What is Genelabs Technologies's location?
Genelabs Technologies's location is
United States
When was Genelabs Technologies's founded?
Genelabs Technologies's founding year is 1983
What is Genelabs Technologies's funding?
Genelabs Technologies's funding is 17,300,000 USD
What is Genelabs Technologies's current status?
Genelabs Technologies's current status is acquired
Top Genelabs Technologies Employees
Senior Manager, Purchasing
bbivens@genelabs.com
+1707-326-5561
Chief Executive Officer
fdriscoll@flexiontherapeutics.com
+1781-305-7777
Scientist Iii
jillb@genelabs.com
Consultant
Sr Aiii
aarfsten@genelabs.com
Classificador
Field Services Engineer